In October 2021, Malachite formed Graphium as a wholly-owned subsidiary and transferred all of its drug development assets to this newly-formed entity. Graphium is advancing a broad portfolio of ...
CLEVELAND, OHIO, April 05, 2023 (GLOBE NEWSWIRE) -- MALACHITE INNOVATIONS, INC. (OTC Mkts: MLCT) (“Malachite”), a public company focused on improving the health and wellness of people and the planet, ...